Clinical Trial Update: Raloxifene for Women With Alzheimer's Disease [Phase 2]

View source ↗

Summary

Results from a Phase 2 trial of raloxifene in women with Alzheimer's disease have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Evista (raloxifene)

Snippet

Sponsor: Stanford University | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-04-02